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Abstract
Dexamethasone-induced muscle atrophy is due to an increase in protein breakdown and a
decrease in protein synthesis, associated with an over-stimulation of the autophagy-lyso-
somal pathway. These effects are mediated by alterations in IGF-1 and PI3K/Akt signaling.
In this study, we have investigated the effects of β-Hydroxy-β-methylbutyrate (HMB) on the
regulation of autophagy and proteosomal systems. Rats were treated during 21 days with
dexamethasone as a model of muscle atrophy. Co-administration of HMB attenuated the ef-
fects promoted by dexamethasone. HMB ameliorated the loss in body weight, lean mass
and the reduction of the muscle fiber cross-sectional area (shrinkage) in gastrocnemius
muscle. Consequently, HMB produced an improvement in muscle strength in the dexa-
methasone-treated rats. To elucidate the molecular mechanisms responsible for these ef-
fects, rat L6 myotubes were used. In these cells, HMB significantly attenuated lysosomal
proteolysis induced by dexamethasone by normalizing the changes observed in autopha-
gosome formation, LC3 II, p62 and Bnip3 expression after dexamethasone treatment. HMB
effects were mediated by an increase in FoxO3a phosphorylation and concomitant de-
crease in FoxO transcriptional activity. The HMB effect was due to the restoration of Akt sig-
naling diminished by dexamethasone treatment. Moreover, HMB was also involved in the
regulation of the activity of ubiquitin and expression of MurF1 and Atrogin-1, components of
the proteasome system that are activated or up-regulated by dexamethasone. In conclu-
sion, in vivo and in vitro studies suggest that HMB exerts protective effects against dexa-
methasone-induced muscle atrophy by normalizing the Akt/FoxO axis that controls
autophagy and ubiquitin proteolysis.
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Introduction
Muscle atrophy occurs in various conditions such as fasting or disuse as well as in diseases in-
cluding cancer, diabetes, AIDS, sepsis, denervation or glucocorticoid treatment. It happens
when proteolysis exceeds protein synthesis, which leads to a reduction of muscle fiber cross-
sectional area and a decrease in muscle strength [1]. In muscle cells, proteolysis is essentially
mediated by the activity of two highly conserved and independent systems, the autophagic-ly-
sosomal and the ubiquitin-proteasomal pathways [2–4].
Autophagy is a physiological process utilized by skeletal muscle to sequester cytoplasmic
proteins and organelles into vacuoles known as autophagosomes. These fuse with lysosomes,
leading to the digestion of the contents by lysosomal hydrolases [3]. Autophagy is vital for re-
moving aged and damaged cellular components, the breakdown of undedicated nutrient stores,
and the remodeling of cellular architecture. However, examination of various skeletal muscle
disorders has shown that the autophagic system is over-stimulated in different conditions
leading to muscle atrophy [3,4]. Upregulation of autophagy and lysosomal genes has been doc-
umented at the transcript and protein level (microtubule-associated protein I light chain 3
(LC3), p62 and Bnip3) in atrophying muscles [2].
In the ubiquitin proteasome system, most soluble and myofibrilar muscle proteins are tar-
geted for degradation through attachment of ubiquitin molecules. The ubiquitin ligases, Atro-
gin-1 and MURF1, are markedly induced during early states of muscle atrophy [4–7].
Interestingly, the rate of muscle atrophy is markedly reduced by targeted inactivation of these
genes [8]. These pathways are regulated by specific transcription factors, such as Forkhead
box O (FoxO) [4,9,10] which are normally phosphorylated and inactivated by Akt in the cyto-
sol, rendering them unable to enter the nucleus [5,6].
Glucocorticoids have been used in in vitro [10] and in vivo [7] models of muscle atrophy.
The signaling pathway stimulated by glucocorticoids involved a decrease in protein synthesis
and an upregulation of atrogenes, in part through a reduction in PI3K/Akt signaling and a con-
comitant increase in FoxO activity [2,5]. In rats, treatment with IGF-1 reverted the upregula-
tion of autophagy-related genes and ubiquitin proteasome elements induced by glucocorticoids
[6].
β-Hydroxy-β-methylbutyrate (HMB) is a leucine metabolite. Positive effects of HMB on
muscle protein turnover in animal models of muscle wasting due to sepsis, age or disuse have
been described [11–13]. Experiments carried out in cell cultures have proposed that HMB ef-
fects are mediated via the MAPK/ERK and PI3K/Akt pathways [14,15] and have focused main-
ly on the proteasomal pathway [16]. However, no effort has been made to study the effects of
HMB on the autophagic-lysosomal pathway in muscle.
In the present study, we have investigated the effects of HMB on a rat model of muscle
wasting induced by DEX. In this model HMB exerts positive effects on lean body mass recov-
ery and functionality. In a well-established in vitromodel of muscle atrophy induced by
DEX, we studied the effects of HMB on the autophagic-lysosomal and ubiquitin proteasome
pathways. The main finding indicates that HMB could contribute to preventing the deleteri-
ous effects of glucocorticoids by targeting FoxO, as the key player that orchestrated not only
ubiquitin proteasomal system but also the autophagic-lysosomal pathway. In fact, for the
first time, our results point to the involvement of HMB in minimizing muscle protein degra-
dation through modulation of the autophagic-lysosomal system. Taken together, these results
support a new mechanism in which HMB may prevent glucocorticoid-induced
muscle atrophy.
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Materials and Methods
Materials
HMB and DEX were purchased from Sigma (St. Louis, MO, USA). HMB calcium salt (Ca-HMB)
was from Technical Sourcing International, Inc., Missoula, MT (purity 98.5%). Tissue culture
media, Fetal Bovine Serum (FBS) and supplements were from Sigma. ERK1/2 and phospho-
ERK1/2 E10 (Thr202/Tyr204), PKB/Akt and phospho-PKB/Akt (Ser473), S6K1 and phospho-
S6K1 (Thr389) antibodies were from Cell Signaling Technology (Beverly, MA, USA). FKHRL1
(FoxO3A), p-FKHRL1 (FoxO3a) (Thr32), MuRF1 and SQSTM1 (p62) antibodies were from
Santa Cruz Biotechnology (Santa Cruz, CA, USA). FBXO32 (Atrogin-1) antibody was from
Acris Antibodies GmbH (Herford, Germany). LC3 antibody was fromMBL International
Corporation (Buckingham, UK). The Cignal FoxO Reporter (luc) kit (CCS-1022L) was from
SABiosciences (Quiagen Inc. Valencia, California). Plasmid pGFP-LC3 was kindly provided
by Professor T. Yoshimori (Department of Genetics, Osaka University), Addgene plasmid
#21073. HRP-conjugated secondary antibodies were from BIO-RAD (Madrid, Spain).
Animals
Male Sprague Dawley rats (8~10 weeks-old) weighing 237.5 ± 2.5 g were housed in standard
plastic cages under controlled environmental conditions (22 ± 3°C temperature, 50 ± 20% hu-
midity, a light/dark cycle of 12 hours each and 15–20 fresh air changes per hour). Animals
were housed group-wise (2–3 animals per cage) and were fed ad libitum a certified Irradiated
Laboratory Rodent Diet (Nutrilab brand, Tetragon Chemie Pvt. Ltd., Bangalore). All the ani-
mals were kept under acclimatization for a period of about 5–7 days before initiation of
the experiment.
Three experimental groups were defined: Control (n = 6), DEX (n = 7) and HMB/DEX
(n = 7). Ca-HMB to the HMB/DEX group was administered in drinking water (320 mg/kg/BW)
[13] from 7 days prior to DEX treatment and mantained during the full time-course of the ex-
periment. DEX was administered intraperitoneally once a day in a dose of 0.1mg/kg body
mass. A control group received saline only. Initiation of DEX injection was considered as day
0 and treatment was carried out for 21 days. Body weight and food intake were recorded daily
until the end of the study. On day 21, all the animals were sacrificed with carbon
dioxide euthanasia.
Ethics Statement
This study was conducted in accordance with the regulations of the Committee for the Purpose
of Control and Supervision of Experiments on Animals (CPCSEA), Government of India and
Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) compli-
ance. The ‘Form B’ for carrying out animal experimentation was reviewed and approved by the
Institutional Animal Ethics Committee (SYNGENE/IAEC/286/03-2012). All aspects of the
protocol and experimental design, including animal number, anesthesia and euthanasia meth-
odologies were provided.
Body composition analysis
Body composition analyses were performed using ECHO-MRI (Model no 900, EchoMRI LLC,
Houston, TX 77079).
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Histochemistry and cross-sectional area measurements
At the end of the experiment, rats were sacrificed with carbon dioxide euthanasia. Soleus and
gastrocnemius muscles were weighed. Unilateral gastrocnemius was preserved in 10% neutral
buffered formalin for muscle fiber morphometric analysis.
After tissue fixation, processing and embedding, muscles were cut into 5–7 μm thick
transverse sections using a microtome (Microm, HM340E Germany) and mounted on glass
slides. Samples were stained with hematoxylin and eosin (H&E) using an autostainer (Leica
ST5010, Germany). Transverse sections of muscle were randomly selected and photographed
using light microscopy (Nikon Eclipse 80i, Japan) with a digital camera (Leica DFC425C,
Germany). Six microscopic fields per muscle were analyzed at 40x magnification. The surface
area of individual muscle bundles was measured and expressed as μm2 using “Leica Applica-
tion Suit” analysis bundle. Cross-sectional areas were determined for at least 300 muscle
fibers per animal. The areas with sectioning artifacts and edges were excluded while taking
photomicrographs.
Functionality measures
The grip strength test was used as a measure of limb strength. In this procedure, the grip
strength meter (Model—0271–004 M, Columbus Instruments, USA) was set in tension mode
and tared before each measurement [17].
Cell culture
The L6.C11 rat skeletal muscle myoblast line (ECACC No. 92102119) was grown in DMEM
supplemented with 10% (v/v) FBS, 2 mmol/l glutamine plus 100 units/ml penicillin and 0.1
mg/ml streptomycin in an atmosphere of 5% CO2 and 95% air, and was maintained at sub-
confluent densities in the growth media. Cells were differentiated into myotubes by culturing
them for 5 days in DMEM containing 2% FBS (v/v).
Determination of protein synthesis
Protein synthesis was measured as described by Gulve et al. [18] with the following modifica-
tions. L6 cells were plated in 48-well tissue culture plates and differentiated for 5 days. Cells
were treated with 25 μMHMB for two hours in DMEM with 10% FBS and 0.8 mM L-Tyrosine
and then for 1 h with 5 μMDEX in the absence or presence of effectors. Cells were then spiked
with 1 μCi/ml of L-[ring-3,5–3H]-Tyrosine (Perkin Elmer, WalthamMA) and were incubated
for 1 h. The reaction was stopped by placing the plates on ice. All wells were thoroughly washed
twice with ice cold PBS media containing 2 mM non-radioactive L-Tyrosine (PBS-Tyr) and the
cells then lysed in 0.1 ml of 0.1 mMNaOH/0.1% sodium deoxycholate. The cellular proteins
were precipitated by adding 0.1 ml of cold 20% trichloroacetic acid (TCA; Sigma). This mixture
was then incubated at 4°C for 15 min. After centrifugation (16,000×g for 10 min at 4°C), the
pellet was washed once with cold 10% TCA and then, the precipitated proteins were dissolved
in 0.1 ml of 1 M NaOH. An aliquot (5 μl) of the NaOH-solubilized material was used for total
protein quantitation and the remaining dissolved proteins were neutralized with 1 M HCl,
mixed with ReadySafe scintillation fluid (Beckman Coulter, Brea CA) and radiolabel deter-
mined with a scintillation counter (Beckman Coulter). Data was computed as dpm/μg
of proteins.
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Protein degradation
Myotubes (5 days in differentiation media) were labeled with 1 μCi/ml of L-[ring-3,5–3H]-Ty-
rosine for 48 h in DMEM plus 10% FBS in presence or absence of 25 μMHMB. Cells were
rinsed once in PBS-Tyr and then placed in DMEM supplemented with 10% FBS, 2 mM L-tyro-
sine plus 5 μMDEX (degradation medium) for 2 h to allow degradation of very short-lived
proteins. The cells were then rinsed twice in PBS-Tyr and fresh degradation medium was
added. Cells were incubated for an additional 24 h in degradation medium. Degradation rates
were determined as previously described [19].
Autophagy Assay
pGFP-LC3-expressing L6 myotubes were used to assess autophagy. L6 myoblasts were tran-
siently transfected with pGFP-LC3 vector and then differentiated into myotubes for 3 days.
Cells were used at 80–90% confluence and transfection was performed using LipofectAMINE
2000 (Invitrogen). 5 hours later the transfection reagent was removed and fresh medium was
added to the cultures. In the case of cultures set to differentiate into myotubes, differentiation
medium was added 24 h later and during 3–5 days. L6 transfected myotubes were pre-incubat-
ed for 30 min with 25 μMHMB and then incubated for 30 min with 5 μMDEX in the presence
or absence of effectors. 100 nM Bafilomycin A1 was added concomitantly with the effectors
and remained in the culture throughout the treatment. Cells were fixed with 2% paraformalde-
hyde in PBS for 15 minutes at room temperature and coverslips were mounted on glass slides
using Vectashield mounting media (Vector Laboratories, Inc., Burlingame, CA). Confocal mi-
croscopy was performed on a Leica DMI6000 confocal microscope. eGFP was excited using the
488 nm line of a krypton/argon laser and the emitted fluorescence was detected with a 504–562
nm channel. All samples were exposed to laser for a time interval not>5 min to avoid photo-
bleaching. The laser was set to the lowest power able to produce a fluorescent signal. Maximum
voltage of photomultipliers was used to decrease the required laser power as much as possible.
A pinhole of 1 Airy unit was used. Images were acquired at a resolution of 1024 x 1024. Series
were acquired in the xyz mode. Data was processed using Leica AF software package. Autopha-
gosomes were quantified by counting GFP-LC3-positive dots.
Protein phosphorylation analysis
To study the phosphorylation status of the proteins involved in signaling events, L6 myotubes
were incubated with 25 μMHMB for 1h and then treated in the absence or presence of 5 μM
DEX for 30 min. Plates were flash frozen in liquid nitrogen and processed as described previ-
ously [20,21].
To study the expression of proteins associated with protein degradation, L6 myotubes were
pre-incubated for 48 h with 25 μMHMB and then incubated for 24 h with 5 μMDEX in the
presence or absence of effectors. When 100 nM Bafilomycin A1 was used, it was added con-
comitantly with DEX and remained in the culture throughout the treatment. After treatment,
they were lysed with RIPA buffer supplemented with phosphatase and protease inhibitors,
10 mM sodium fluoride, 10 mM sodium pyrophosphate, 1 mM sodium orthovanadate, 1 mM
EGTA, 20 nM okadaic acid, 10 μg/ml aprotinin, 10 μg/ml leupeptin and 10 μg/ml pepstatin.
The protein concentration was measured using the bicinchoninic acid method [22]. Pro-
teins (40 μg) were separated by SDS-PAGE, transferred onto nitrocellulose membranes, and
immunoblotted with specific antibodies; the immunoblots were developed by an enhanced
chemiluminescence detection method.
HMB Normalizes Autophagy in Skeletal Muscle
PLOS ONE | DOI:10.1371/journal.pone.0117520 February 6, 2015 5 / 20
RNA Purification and Retrotranscription
Total RNA was isolated from L6 myotubes using the GeneJet RNA Purification Kit (Thermo
Scientific). The amount of total RNA was measured using a NanoVue Plus Spectrophotometer
(GE Healthcare Life Sciences) and the quality was verified by 1% agarose gel electrophoresis. 1
μg of total RNA from each sample was reverse-transcribed using Maxima First Strand cDNA
Synthesis Kit for RT-qPCR (Thermo Scientific).
Quantitative Real-time PCR (qPCR)
The qPCR was performed using specific primers on a MiniOpticon Real-Time PCR System
(Bio-Rad) with Bio-Rad CFX Manager 3.1 software and fluorescence signal detection (SYBR
Green) after each amplification cycle. Sequences of the primers were for β-actin, forward 5’-
AAGACCTCTATGCCAACAC-3’ and reverse 5’-TGATCTTCATGGTGCTAGG-3’; Bnip3,
forward 5’- CTACTCTCAGCATGAGAAAC-3’ and reverse 5’-TCCAATGTAGATCCC
CAATC-3’; murf (Trim63), forward 5’-GTTTACTGAAGAGGAGGAGG-3’ and reverse 5’-
AGAAGACACACTTCCCTATG-3’; Atrogin-1 (Fbxo32), forward 5’-TACAACTGAACAT
CATGCAG-3’ and reverse 5’- GTACATCTTCTTCCAATCCAG-3’. First strand cDNA was
used as a template in 10 μl reactions including 5 μl of 2x iTaq Universal SYBR Green supermix
and 500 nM of each primer. Negative controls (with no DNA template) for each primer set
were included in each run. qPCR cycling was performed at 95°C (2 min), followed by 40 cycles
at 95°C (15 s), 57°C (30 s), and, finally, a melt curve program (60–95°C with a heating rate of
0.1°C/s and a continuous fluorescence measurement). Measurements of gene expression with
regard to each RNA extraction were obtained in triplicate. Relative expression of mRNA was
calculated using the 2−ΔCt method with β-actin as an internal reference gene.
Reporter gene constructs and assays
For the analysis of rat Ubiquitin (UbC) promoter, a 417 bp fragment flanking the transcription
start point was amplified from rat genomic DNA. This fragment is similar to those character-
ized for human and rat promoters [20]. Sequences of all constructs were verified by automated
DNA sequencing. The Cignal FoxO Reporter (luc) kit contains a mixture of inducible FoxO-re-
sponsive firefly luciferase construct and constitutively expressing Renilla luciferase construct
(40:1).
For gene reporter analysis, cells were used at 80–90% confluence. Transfection was per-
formed using LipofectAMINE2000 as described above. The DNA mixture comprised the
pGL3-UbC luciferase reporter and the reference plasmid pRL-TK (ratio 95:5) or the Cignal
FoxO Reporter mixture.
L6 myotubes were incubated in presence or absence of 25 μMHMB for 48 h. Cells were
then incubated in the presence or absence of 5 μMDEX for 24 h. Luciferase activity was deter-
mined using the Dual Luciferase method (Promega) in a luminometer (Sirius L, Berthold Tech-
nologies, Bad Wildbad, Germany) and results were standardized for Renilla luciferase activity.
To allow comparison of the expression patterns, the data are expressed as relative changes in
luciferase activity and were normalized to a value of 100%.
Statistics
Results are expressed as mean ± SEM. Statistical analysis was performed by one way ANOVA
followed by Tukey test as appropriate. P< 0.05 was considered statistically significant.
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Results and Discussion
Many pathological states characterized by muscle atrophy are associated with an increase in
glucocorticoid levels [7,10]. The enhancement of muscle proteolysis by glucocorticoids results
from a decrease in the PI3K/Akt signaling and the concomitant activation of the ubiquitin pro-
teasome and lysosomal autophagy systems [7].
In muscle atrophy, the altered protein turnover is due mainly to an increase in the rate of
protein breakdown. This process is mediated by an induction of the ubiquitin proteasome sys-
tem, involving an increase in ubiquitin activity and ubitiquin ligase levels [4–7].
Autophagy is a physiological house-keeping process involved in protein and organelle deg-
radation with cell-protective functions [23]. However, defective regulation of autophagy leads
to myopathy. Thus, tight control of the autophagic flux must be mantained in order to preserve
muscle mass and prevent wasting [24].
Ubiquitin-Proteasome activity and autophagy have been described as likely to proceed in an
independently coordinated manner [5,6]. This could be explained by the existence of a com-
mon transcription factor that orchestrates muscle atrophy by controlling both pathways. In
fact, FoxO has been identified as the master regulator of both processes in skeletal muscle [9].
In the present study we have shown that HMB exerts protective effects against muscle atro-
phy promoted by DEX in vivo and in vitro. In our model of muscle atrophy, administration of
HMB attenuates the loss in lean mass, restores muscle functionality and recovers the shrinkage
of the fibers. By using L6 muscle cells in culture, we have shown that the effects of HMB were
mediated by modulation of the formation of autophagosomes and of the expression of LC3,
p62 and Bnip3, all belonging to the autophagic-lysosomal system. Moreover, we found that
HMB prevents proteolysis by controlling the proteasome pathway. The effects of HMB were
mediated by an increase in PI3K/Akt signaling and the phosphorylation of FoxO3a.
HMB protects against DEX-induced muscle atrophy in a rat model
To study the effects of HMB on a DEX-induced muscle wasting model, rats were treated either
with DEX (0.1 mg/kg) or DEX plus Ca-HMB (320 mg/kg) for 21 days. Administration of HMB
was initiated 7 days prior to DEX treatment as a preventive approach. Our results showed that
DEX caused a progressive loss of body weight compared to control rats (Fig. 1A) while admin-
istration of HMB to DEX rats significantly attenuated body weight loss from day 18.
To analyze whether the changes in body weight were due to changes in lean mass, Echo
MRI determinations were carried out. As shown in Fig. 1B, the control group gained lean mass
whereas DEX induced a gradual decline throughout the treatment. Co-administration of HMB
attenuated the loss of lean mass, having significant effects at day 14. The amelioration in body
weight and lean mass produced by HMB was parallel to the changes in wet weight of soleus
(Fig. 1C) and gastrocnemius (Fig. 1D) muscles measured at the end of the experiment.
To gain further insights into the effects of HMB on skeletal muscle under DEX treatment,
the cross-sectional areas of gastrocnemius muscle fibers were determined. DEX promoted a re-
duction in the cross-sectional area (Fig. 2A) compared with the control group while co-treat-
ment with HMB demonstrated a significant attenuation in the loss of cross-sectional area.
Finally, to determine if the changes in lean mass and fiber cross section correlated with mus-
cle functionality, a grip strength test was conducted throughout the timecourse of the experi-
ment. As shown in Fig. 2B, treatment with DEX decreased muscle functionality starting from
day 15, whereas co-administration of HMB with DEX completely normalized
muscle performance.
Our results suggest that significant HMB protection was provided after at least 14–18 days
of treatment (Fig. 1). These results are in agreement with those of Hao et al. [25], who reported
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that 28 days HMB supplementation was able to improve skeletal muscle functionality in a
model of fiber atrophy in aged rats. In contrast, a recent study [26] has reported that HMB sup-
plementation for 7 days did not attenuate cross sectional area in muscle fibers or improved
skeletal muscle performance in rats under DEX treatment. This discrepancy is probably due to
the differences in the length and nature of the treatment (7 days versus 21 days). In fact, our re-
sults for body weight, lean body mass and muscle functionality show that at least 15–18 days
were necessary to produce a significant recovery from DEX treatment. Moreover, in our experi-
mental design HMB was given in drinking water ad libitum instead of in a single oral dose, en-
suring that sustained circulating plasma concentrations of HMB were maintained during
the experiment.
Effects of HMB on protein turnover in DEX-treated myotubes
Having established the positive effects of HMB on the DEX rat model of muscle atrophy, an
L6 myotube culture was used to elucidate the HMB molecular bases of action. L6 myotubes
have been previously used as an in vitro system to determine the effects of HMB on protein
turnover [16]. In our experiments, L6 cells were differentiated into myotubes, pre-incubated
with or without 25 μMHMB and then incubated in the presence or absence of 5 μMDEX, as
described in the methods section.
First, the effects of HMB on protein degradation and protein synthesis induced by DEX
were analyzed. Incubation with DEX induced a significant increase in protein degradation and
a decrease in protein synthesis compared with untreated L6 myotubes (Fig. 3). HMB adminis-
tration to myotubes significantly decreased proteolysis induced by DEX and was also able to at-
tenuate the decrease in protein synthesis produced by the glucocorticoid treatment. Therefore,
these results validate the use of L6 myotubes incubated with DEX as a cellular model of muscle
atrophy to study the effects of HMB.
Effects of HMB on autophagy
Autophagy is a process that allows cell degradation, and, consequently, the recycling of cytosol-
ic proteins and organelles in response to starvation. Autophagy is also responsible for the deg-
radation of protein aggregates, which would accumulate and be toxic for the cell [27]. This
process is coordinated by a battery of genes. The term autophagic flux describes autophagy as a
dynamic process, that includes autophagosome formation, maduration and fusion with lyso-
somes with the consequent breakdown and release of macromolecules back into the cytosol
[28].
One remarkable result obtained in the animal model was a reduction in the shrinkage of
muscle fibers and an improvement in muscle functionality by HMB. Since DEX-induced mus-
cle wasting has been correlated with an increase in autophagy as an altered remodeling process
[29], the effects of HMB on the formation of autophagosome vesicles after DEX exposure were
evaluated. The most used methods to monitor autophagic activation are based on the detection
of autophagosome formation by fluorescence microscopy and the analysis of LC3 processing
by western blot [30].
For the analysis of autophagy, L6 cells were transfected with a GFP-LC3 plasmid and differ-
entiated into myotubes. Next, the numbers of GFP-positive punctae/cell were counted. Our
Fig 1. Effects of HMB supplementation on body weight, lean bodymass andmuscle weight in DEX-treated rats. (A) Body weight and (B) lean body
mass analysis of each group (Control, DEX and HMB/DEX). Day 0 was considered as the day of initiation of dexamethasone treatment. Wet weight (grams)
of soleus (C) and gastrocnemius (D) for each group at the end of the experiment. Values are expressed as mean ± SEM (n = 7). ap<0.05 compared with
Control group. bp<0.05 compared with DEX group.
doi:10.1371/journal.pone.0117520.g001
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results showed that DEX treatment induced an increase in the formation of autophagosomes
(Fig. 4). In contrast, pre-incubation of myotubes with HMB was able to decrease formation of
GFP-autophagosomes induced by DEX. Moreover, puncta formation was not changed by
HMB in the absence of DEX.
The amount of LC3-II, a lipidated form of LC3, is closely related to the number of autopha-
gosomes [30]. LC3-II is located on the inner and outer membranes and is indispensable for
membrane biogenesis and closure of the membranes [31]. Once the autophagosome is mature,
the LC3-II located on the outer membrane is cleaved off by Atg4B and recycled, while the
LC3-II on the inner membrane is degraded by lysosomal enzymes [3]. If cells are treated with
Bafilomycin A1, an autophagosome-lysosome fusion inhibitor, degradation of LC3-II is par-
tially inhibited whereas that of LC3-I is not affected [30]. The changes in the LC3 lipidation
process induced by DEX leading to the synthesis of LC3-II were normalized by HMB treat-
ment. These results have been confirmed by the use of bafilomycin A1 (Fig. 5A). Bafilomycin
prevents the lysosomal degradation of LC3-II and allows a better analysis of the autophagic
process [30]. In the presence of Bafilomycin A1, an increase in the expression of LC3-II and
concomitant decrease in LC3-I was observed in the DEX-treated cells. HMB was again able to
normalize the amount of LC3-II.
Monitoring the degradation of p62 (SQSTM1/sequestosome-1) is an alternative method to
detect the autophagic flux [3, 27]. p62 is an ubiquitin-associated protein that interacts directly
with LC3-II [32]. In the absence of Bafilomycin A1, the level of p62 decreased in response to
DEX treatment while pre-incubation with HMB restored its expression (Fig. 5B). It is interest-
ing to point out that incubation with HMB alone increased p62 levels. It is described that p62 is
degraded by both the autophagy and ubiquitin-proteasome systems [32] and the increase due
to HMB incubation could be due to an inhibition of the proteasome. In contrast, when cells
were treated with an inhibitor of autophagosome lysis, DEX promoted an increase in p62 levels
Fig 2. Effects of HMB supplementation onmorphometric analysis and hind limb strength in DEX-treated rats. (A)Muscle fiber cross-sectional area
(μm2). Measurements were made 21 days post treatment. (B) Hind limb strength in animals submitted to saline, DEX or HMB/DEX. Values are expressed as
mean ± SEM (n = 7). ap<0.05 compared with Control group. bp<0.05 compared with DEX group.
doi:10.1371/journal.pone.0117520.g002
Fig 3. Effect of HMB on protein degradation and synthesis in rat L6 myotubes treated with DEX.
Results are shown as the increase in protein degradation and the decrease in protein synthesis (%) due
to the presence of DEX when compared with basal levels (non-treated cells). Results are expressed as
means ± SEM (n = 8).ap< 0.05 compared with DEX treated cells.
doi:10.1371/journal.pone.0117520.g003
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Fig 4. Effects of HMB supplementation on the autophagosome formation induced by DEX. Autophagosomes were quantified by counting GFP-LC3
punctae/cell of at least 4 fields per treatment. Scale bar in the microphotographs corresponds to 25 μm. Results represent means ± SEM (n = 4).a p< 0.05
compared with untreated control cells; b p< 0.05 compared with DEX-treated cells.
doi:10.1371/journal.pone.0117520.g004
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that was reverted by pre-incubation with HMB. Taken together, the p62 results sustained the
idea that HMB is able to counteract DEX induced autophagy.
To gain further insights into the regulation of the autophagy pathway, mRNA levels of
Bnip3, as an inductor of autophagosome formation [9, 27], were measured. HMB reduced the
increase in the mRNA levels of Bnip3 caused by DEX treatment (Fig. 5C).
Finally, we analyzed the phosphorylation of S6K1 as a marker not only related to protein
synthesis but also to an increase in autophagy [33]. DEX treatment induced a decrease in the
activation of S6K1. In contrast, pre-treatment with HMB was able not only to block the effects
induced by DEX but also to significantly increase the phosphorylation of S6K1 (Fig. 5D).
Taken together, the effects of HMB on GFP-LC3 punctae, on the expression of LC3-II, p62
and Bnip3 as well as on S6k1 phosphorylation levels clearly establish a normalization of autop-
hagic flux as a model of action for HMB on DEX-induced muscle atrophy. This is the first time
that the effects of HMB on muscle wasting have been associated with normalization of autop-
hagy, and the elucidation of the molecular bases for HMB regulation of autophagy are relevant
in order to validate the potential beneficial effects of HMB on muscle wasting conditions. Fur-
thermore, it should be remembered that the addition of HMB does not change the basal levels
of autophagy of control cells and thus does not block this essential muscle process [24] under
normal conditions.
HMB decreases FoxO transcriptional activity in DEX-treated myotubes
It has been reported that Foxo3a induces the expression of autophagy-related genes [5,6,9] in-
cluding LC3 and Bnip3. The role of FoxO, as a transcriptional activator, is typically inhibited
by insulin [27]. In contrast, DEX acts as a FoxO activator by inhibiting the PI3K/Akt signaling
pathway [7]. Since FoxO has been established as the key element for DEX-induced autophagy,
we studied the effects of HMB on the phosphorylative status of FoxO3a and FoxO-dependent
transcriptional activity.
DEX treatment decreased FoxO3a at Thr32 phosphorylation (Fig. 6A) with a concomitant
increase in FoxO-dependent transcriptional activity (Fig. 6D). Treatment with HMB normal-
ized FoxO3a phosphorylation and consequently inhibited FoxO transcriptional activity. It
should be noted that HMB alone was unable to significantly change the phosphorylative status
of FoxO or its transcriptional activity compared with control cells. This result is in agreement
with the levels of autophagy obtained in control or HMB-treated cells.
FoxO transcriptional activity is mainly regulated by phosphorylation. Protein kinases such
as Akt directly phosphorylate FoxO factors, resulting in sequestration at the cytosol and repres-
sion of their transcriptional activity [2,5,6,7,9,27]. The three key phosphorylation sites in
FoxO3A are Thr32, Ser253, and Ser315, corresponding with a consensus sequence for Akt
phosphorylation [34]. On the other hand, the effects of DEX on muscle wasting have been as-
cribed to a hypo-phosphorylation of FoxO and concomitant migration to the nucleus through
inhibition of the corresponding kinases [6,7].
Previous experiments have suggested that the effects of HMB on muscle could be mediated
via the PI3K/Akt and MAPK/ERK pathways [13,14]. Consequently, we assayed the effects
of HMB in the presence or absence of DEX on the phosphorylation status of PKB/Akt and
ERK1/2. DEX significantly reduced the phosphorylation of PKB/Akt and ERK1/2 while HMB
Fig 5. Effects of HMB supplementation on the regulation of LC3, p62, Bnip3 and S6K1 expression induced by DEX. (A) Immunoblotting for LC3 in
absence or presence of Bafilomycin A1. Two bands are shown, corresponding to LC3-I and the lipidated form LC3-II. (B) Levels of p62 were evaluated by
immunoblot analysis in the absence or presence of 100 nM Bafilomycin A1. (C)mRNA levels for Bnip3 were measured by quantitative real-time PCR
analysis in samples from all the experimental groups (n = 8). (D) Phosphorylation level of S6K1. Signal densities from untreated cells were assigned a value
of 100%. Results are expressed as means ± SEM (n = 4). a p< 0.05 compared with untreated cells and b p< 0.05 compared with DEX-treated cells.
doi:10.1371/journal.pone.0117520.g005
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Fig 6. Effects of HMB on the phosphorylation of FoxO3a, Akt and ERK1/2 and on FoxO transcriptional activity in presence of DEX. Cells were lysed
and total protein was immunoblotted with specific phospho- and total-antibodies against FoxO3 (A), Akt/PKB (B) or ERK1/2 (C). Signal densities from
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significantly stimulated the phosphorylation of both kinases. When HMB-pretreated cells were
incubated with DEX, the phosphorylative status of PKB/Akt remained higher than that of con-
trol cells (Fig. 6B) while the activation of ERK1/2 was similar to that observed in the untreated
cells (Fig. 6C). Therefore, both pathways were restored by HMB treatment in the DEX cells.
To assess the involvement of either PKB/Akt or ERK1/2 on the HMB-mediated modulation
of FoxO transcriptional activity, L6 myotubes transfected with the FoxO reporter were pre-in-
cubated with inhibitors of PKB/Akt (20 μM LY294002) or ERK1/2 (10 μM PD98059) mediated
signaling prior to treatment with HMB and DEX (Fig. 6D). While the inhibition of the ERK1/2
signaling pathway did not change either the effects of DEX or HMB on FoxO-dependent tran-
scriptional activity, the blockade of Akt signaling induced an increase in FoxO activity in un-
treated cells as expected [7] and blocked the effects of HMB in DEX-treated cells. Thus, the
effect of HMB in reducing the activity of FoxO in DEX-treated cells was due to a re-activation
of PKB/Akt signaling and was independent of ERK 1/2 pathway.
Finally, to illustrate the dependence of the Akt vs mTOR in the HMB-induced suppression
of autophagy, myotubes were treated with DEX or HMB + DEX in the presence of LY294002,
an Akt inhibitor, or rapamycin, a mTOR inhibitor and the effects on LC3-II expression as a
marker of autophagy were assayed. Immunoblots of LC3-II showed that the HMB-induced
suppression of autophagy was strongly dependent of the Akt signaling compared with the
mTOR pathway (S1 Fig.).
HMB pre-treatment decreases ubiquitin promoter transcriptional activity
and atrogenes expression in DEX-treated myotubes
Most studies of the beneficial effects of HMB in preventing proteolysis in muscle are based on
the total or partial decrease in the expression of ubiquitin ligases [16, 35] as components of the
proteasome system. However, the effects of HMB on the transcription of the ubiquitin gene
have not been reported.
An in silico analysis of the rat ubiquitin promoter using PROMO software [36] showed the
existence of two binding sites for FoxO3a (at positions -199 and -381). Since, in muscle atro-
phy, the Ub-C mRNA increased more than other ubiquitin mRNAs (ie UbA and UbB) [37] we
used a reporter system based on the rat Ub-C promoter fused to a luciferase gene as a sensitive
marker for analyzing general activation of the Ub-proteasome. Furthermore, atrogin-1 and
MuRF1 (E3-ubiquitin ligases) are, at least in part, under the control of FoxO3a [29]. Therefore,
the effects of DEX and HMB on the transcription of the ubiquitin gene (Fig. 7A) and the ex-
pression and mRNA levels of both ubiquitin ligases have been assayed (Fig. 7B- 7E).
Our results showed that DEX treatment induced an increase in Ub-C promoter activity
while pre-treatment with HMB was able to significantly counteract the effects of DEX on Ub-C
promoter activity (Fig. 7A). Furthermore, pre-incubation with HMB significantly reduced the
DEX-induced expression and mRNA levels of Atrogin-1 (Fig. 7B and 7C) and MuRF1 (Fig. 7D
and 7E). In the absence of DEX, HMB did not modify the basal amount of either of the ubiqui-
tin ligases. Our results indicate that HMB is able to decrease ubiquitin-dependent protein
breakdown and therefore explain the increase in p62 levels in the presence of HMB [32].
untreated cells were assigned a value of 100%. Results are expressed as means ± SEM (n = 4).a p< 0.05 compared with untreated cells and b p< 0.05
compared with DEX- treated cells. (D) Cells were transiently transfected with a FoxO luciferase reported plasmid and differentiated into myotubes before
treatments to evaluate FoxO-dependent transcription. Cells were pre-incubated for 30 min with 10 μMPD98059 and 20 μM LY294002, then incubated with
25 μMHMB for 48 h and finally incubated with 5 μMDEX in the presence or absence of effectors. Inhibitors were maintained during the experiment. Results
are expressed as means ± SEM (n = 6). ap< 0.05 compared with control cells in the presence of each inhibitor, bp< 0.05 compared with DEX- treated cells
in the presence of each inhibitor and cp< 0.05 compared with control cells in the absence of inhibitors.
doi:10.1371/journal.pone.0117520.g006
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Fig 7. Effects of HMB on Ub-C promoter activity and expression of Atrogin-1 and MuRF1 induced by DEX. (A) Cells were transiently transfected with
an UbC-luciferase reported plasmid and differentiated into myotubes before treatments to evaluate UbC gene transcription (n = 6). Western blots for Atrogin-
1 (B) and MuRF1 (D). Densitometric quantification of protein abundance using actin as a reference control is shown. Signal densities from untreated cells
were assigned a value of 100% (n = 4). mRNA levels for Atrogin-1 (C) and MuRF1 (E) were measured in samples from all the experimental groups (n = 8).
Results are expressed as means ± SEM. ap< 0.05 compared with untreated cells and bp< 0.05 compared with DEX-treated cells.
doi:10.1371/journal.pone.0117520.g007
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Conclusions
HMB exerts protective effects against muscle atrophy promoted by DEX in vivo and in vitro.
Firstly, in vivo experiments demonstrated that co-administration of HMB attenuates loss of
lean mass and the shrinkage of the fibers, and restoring muscle functionality. Secondly, we
demonstrated that the preventive effects of HMB in an in vitromodel of muscle atrophy were
mainly mediated by modulation of the autophagy-lysosomal system. The key element in HMB
normalization of autophagy is the phosphorylation of FoxO3a as a consequence of an increase
in PI3K/Akt signaling in the cytosol. Finally, and given that FoxO also regulates the transcrip-
tion of genes belonging to the proteasomal system, HMB prevents proteolysis by controlling
the activity of ubiquitin and the expression of ubiquitin ligases.
Supporting Information
S1 Fig. Dependence of Akt vs mTOR in the HMB-induced suppression of autophagy. Cells
were pre-incubated for 30 min with 20 μM LY294002 and 20 nM rapamycin, then incubated
with 25 μMHMB for 48 h and finally incubated with 5 μMDEX in the presence or absence
of effectors. Inhibitors were maintained during the experiment. Cells were lysed and total
protein was immunoblotted with LC3 antibody. Results are expressed as means ± SEM
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